telbivudine has been researched along with isomethyleugenol in 1 studies
| Studies (telbivudine) | Trials (telbivudine) | Recent Studies (post-2010) (telbivudine) | Studies (isomethyleugenol) | Trials (isomethyleugenol) | Recent Studies (post-2010) (isomethyleugenol) |
|---|---|---|---|---|---|
| 486 | 85 | 332 | 33,847 | 127 | 11,831 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mao, Q; Ni, B; Ni, D; Song, J; Tian, Y; Tian, Z; van Velkinburgh, JC; Wu, Y; Yang, D; Yang, W; Zhang, Y; Zhao, K | 1 |
1 other study(ies) available for telbivudine and isomethyleugenol
| Article | Year |
|---|---|
Telbivudine treatment corrects HBV-induced epigenetic alterations in liver cells of patients with chronic hepatitis B.
Topics: Antiviral Agents; Case-Control Studies; Chromatin; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression Regulation; Hep G2 Cells; Hepatitis B virus; Hepatitis B, Chronic; Histone-Lysine N-Methyltransferase; Histones; Humans; Inflammation; Liver; Liver Cirrhosis; Methylation; Polycomb Repressive Complex 2; Telbivudine; Thymidine | 2014 |